Product Code: GVR-2-68038-483-3
Embolic Protection Devices Market Growth & Trends:
The global embolic protection devices market size is expected to reach USD 1.09 billion by 2030, according to a new report by Grand View Research, Inc. The market is estimated to expand at a CAGR of 8.7% from 2024 to 2030. Rising incidences of cardiovascular and neurovascular diseases and growing adoption of minimally invasive diseases are propelling the market growth. Rising demand for technologically advanced embolic devices and increasing healthcare expenditure, resulting in huge funding and investments from multinational companies, are fueling the R&D in the global medical devices industry. This factor is also contributing toward the market growth.
On the other hand, the product failures and recalls may limit the market growth. Low reimbursement for stenting and presence of alternative treatment methods, such as the use of drugs, may also imped the market development. However, factors such as a rise in the number of Trans-catheter Aortic Valve Replacement (TAVR) procedures will support the market expansion.
Embolic Protection Devices Market Report Highlights:
- Distal filter devices segment emerged as the largest segment owing to high demand for these devices
- Neurovascular diseases accounted for the largest share in the application segment owing to the rising cases of neurological disorders
- North America led the global embolic protection devices market with the largest share in 2023 and is likely to maintain this trend over the estimated period
- Growing adoption of minimally invasive surgeries and increasing demand for novel technologies are facilitating the dominance of this region
- The industry in the Asia Pacific is projected to witness swift growth during the forecast period owing to rapidly improving healthcare infrastructure and large target population base
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.2. Market Definitions
- 1.3. Research Methodology
- 1.3.1. Information Procurement
- 1.3.2. Information or Data Analysis
- 1.3.3. Market Formulation & Data Visualization
- 1.3.4. Data Validation & Publishing
- 1.4. Research Scope and Assumptions
- 1.4.1. List of Data Sources
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.3. Competitive Insights
Chapter 3. Embolic Protection Devices Market Variables, Trends, & Scope
- 3.1. Market Introduction/Lineage Outlook
- 3.2. Market Size and Growth Prospects (USD Million)
- 3.3. Market Dynamics
- 3.3.1. Market Drivers Analysis
- 3.3.2. Market Restraints Analysis
- 3.4. Embolic Protection Devices Market Analysis Tools
- 3.4.1. Porter's Analysis
- 3.4.1.1. Bargaining power of the suppliers
- 3.4.1.2. Bargaining power of the buyers
- 3.4.1.3. Threats of substitution
- 3.4.1.4. Threats from new entrants
- 3.4.1.5. Competitive rivalry
- 3.4.2. PESTEL Analysis
- 3.4.2.1. Political landscape
- 3.4.2.2. Economic and Social landscape
- 3.4.2.3. Technological landscape
- 3.4.2.4. Environmental landscape
- 3.4.2.5. Legal landscape
Chapter 4. Embolic Protection Devices Market: Product Estimates & Trend Analysis
- 4.1. Segment Dashboard
- 4.2. Embolic Protection Devices Market: Product Movement Analysis, 2023 & 2030 (USD Million)
- 4.3. Distal Occlusion Devices
- 4.3.1. Distal Occlusion Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.4. Proximal Occlusion Devices
- 4.4.1. Proximal Occlusion Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.5. Distal Filters
- 4.5.1. Ovarian Cancer Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Embolic Protection Devices Market: Application Estimates & Trend Analysis
- 5.1. Segment Dashboard
- 5.2. Embolic Protection Devices Market: Application Movement Analysis, 2023 & 2030 (USD Million)
- 5.3. Cardiovascular Diseases
- 5.3.1. Cardiovascular Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.4. Neurovascular Diseases
- 5.4.1. Neurovascular Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.5. Peripheral Vascular Diseases
- 5.5.1. Peripheral Vascular Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Embolic Protection Devices Market: Regional Estimates & Trend Analysis
- 6.1. Embolic Protection Devices Market Share, By Region, 2023 & 2030 (USD Million)
- 6.2. North America
- 6.2.1. North America Embolic Protection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.2.2. U.S.
- 6.2.2.1. U.S. Embolic Protection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.2.3. Canada
- 6.2.3.1. Canada Embolic Protection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.2.4. Mexico
- 6.2.4.1. Mexico Embolic Protection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3. Europe
- 6.3.1. Europe Embolic Protection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.2. UK
- 6.3.2.1. UK Embolic Protection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.3. Germany
- 6.3.3.1. Germany Embolic Protection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.4. France
- 6.3.4.1. France Embolic Protection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.5. Italy
- 6.3.5.1. Italy Embolic Protection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.6. Spain
- 6.3.6.1. Spain Embolic Protection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.7. Denmark
- 6.3.7.1. Denmark Embolic Protection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.8. Sweden
- 6.3.8.1. Sweden Embolic Protection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.9. Norway
- 6.3.9.1. Norway Embolic Protection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.4. Asia Pacific
- 6.4.1. Asia Pacific Embolic Protection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.4.2. China
- 6.4.2.1. China Embolic Protection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.4.3. Japan
- 6.4.3.1. Japan Embolic Protection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.4.4. India
- 6.4.4.1. India Embolic Protection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.4.5. South Korea
- 6.4.5.1. South Korea Embolic Protection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.4.6. Australia
- 6.4.6.1. Australia Embolic Protection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.4.7. Thailand
- 6.4.7.1. Thailand Embolic Protection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.5. Latin America
- 6.5.1. Latin America Embolic Protection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.5.2. Brazil
- 6.5.2.1. Brazil Embolic Protection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.5.3. Argentina
- 6.5.3.1. Argentina Embolic Protection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.6. Middle East and Africa
- 6.6.1. Middle East and Africa Embolic Protection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.6.2. South Africa
- 6.6.2.1. South Africa Embolic Protection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.6.3. Saudi Arabia
- 6.6.3.1. Saudi Arabia Embolic Protection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.6.4. UAE
- 6.6.4.1. UAE Embolic Protection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.6.5. Kuwait
- 6.6.5.1. Kuwait Embolic Protection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Competitive Landscape
- 7.1. Recent Developments & Impact Analysis by Key Market Participants
- 7.2. Company Categorization
- 7.3. Company Heat Map Analysis
- 7.4. Company Profiles
- 7.4.1. Boston Scientific Corporation
- 7.4.1.1. Participant's Overview
- 7.4.1.2. Financial Performance
- 7.4.1.3. Product Benchmarking
- 7.4.1.4. Recent Developments/ Strategic Initiatives
- 7.4.2. Edwards Lifesciences Corporation.
- 7.4.2.1. Participant's Overview
- 7.4.2.2. Financial Performance
- 7.4.2.3. Product Benchmarking
- 7.4.2.4. Recent Developments/ Strategic Initiatives
- 7.4.3. Abbott.
- 7.4.3.1. Participant's Overview
- 7.4.3.2. Financial Performance
- 7.4.3.3. Product Benchmarking
- 7.4.3.4. Recent Developments/ Strategic Initiatives
- 7.4.4. Medtronic
- 7.4.4.1. Participant's Overview
- 7.4.4.2. Financial Performance
- 7.4.4.3. Product Benchmarking
- 7.4.4.4. Recent Developments/ Strategic Initiatives
- 7.4.5. Cardinal Health.
- 7.4.5.1. Participant's Overview
- 7.4.5.2. Financial Performance
- 7.4.5.3. Product Benchmarking
- 7.4.5.4. Recent Developments/ Strategic Initiatives
- 7.4.6. Innovative Cardiovascular Solutions, LLC
- 7.4.6.1. Participant's Overview
- 7.4.6.2. Financial Performance
- 7.4.6.3. Product Benchmarking
- 7.4.6.4. Recent Developments/ Strategic Initiatives
- 7.4.7. Transverse Medical, Inc.
- 7.4.7.1. Participant's Overview
- 7.4.7.2. Financial Performance
- 7.4.7.3. Product Benchmarking
- 7.4.7.4. Recent Developments/ Strategic Initiatives
- 7.4.8. W. L. Gore & Associates, Inc.
- 7.4.8.1. Participant's Overview
- 7.4.8.2. Financial Performance
- 7.4.8.3. Product Benchmarking
- 7.4.8.4. Recent Developments/ Strategic Initiatives